Zhenlin Yang (Shugeng Gao)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Squamous Cell Carcinoma

Ejection Fraction

Top Venues

Thoracic cancer

Cancer gene therapy

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Guangyu Bai, Xiaowei Chen, Yue Peng, Ying Ji, Fenglong Bie, Yang Liu, Zhenlin Yang, Shugeng Gao
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy. Thoracic cancer 15 (14) (2024)
Yang Liu, Fenglong Bie, Guangyu Bai, Qilin Huai, Yuan Li, Xiaowei Chen, Bolun Zhou, Zhenlin Yang
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Guangyu Bai, Xiaowei Chen, Yue Peng, Ying Ji, Fenglong Bie, Yang Liu, Zhenlin Yang, Shugeng Gao
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy. Thoracic cancer (2024)
Guangyu Bai, Xiaowei Chen, Yue Peng, Ying Ji, Fenglong Bie, Yang Liu, Zhenlin Yang, Shugeng Gao
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy. Thoracic cancer 15 (14) (2024)
Yang Liu, Fenglong Bie, Guangyu Bai, Qilin Huai, Yuan Li, Xiaowei Chen, Bolun Zhou, Zhenlin Yang
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 26 (8) (2024)
Yang Liu, Fenglong Bie, Guangyu Bai, Qilin Huai, Yuan Li, Xiaowei Chen, Bolun Zhou, Zhenlin Yang
Prognostic model based on B cell marker genes for NSCLC patients under neoadjuvant immunotherapy by integrated analysis of single-cell and bulk RNA-sequencing data. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2024)
Guangyu Bai, Xiaowei Chen, Yue Peng, Ying Ji, Fenglong Bie, Yang Liu, Zhenlin Yang, Shugeng Gao
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy. Thoracic cancer 15 (14) (2024)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy 30 (3) (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy 30 (3) (2023)
He Tian, Yalong Wang, Zhenlin Yang, Ping Chen, Jiachen Xu, Yanhua Tian, Tao Fan, Chu Xiao, Guangyu Bai, Lin Li, Bo Zheng, Chunxiang Li, Jie He
Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer gene therapy 30 (3) (2023)
Yue Peng, Bin Qiu, Fengwei Tan, Jiachen Xu, Fenglong Bie, Huayu He, Lei Liu, He Tian, Guangyu Bai, Bolun Zhou, Yuan Li, Qilin Huai, Zhenlin Yang, Shugeng Gao
TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma. Thoracic cancer 13 (14) (2022)
Yanhua Tian, Qingqing Li, Zhenlin Yang, Shu Zhang, Jiachen Xu, Zhijie Wang, Hua Bai, Jianchun Duan, Bo Zheng, Wen Li, Yueli Cui, Xin Wang, Rui Wan, Kailun Fei, Jia Zhong, Shugeng Gao, Jie He, Carl M Gay, Jianjun Zhang, Jie Wang, Fuchou Tang
Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer. Signal transduction and targeted therapy 7 (1) (2022)
Renda Li, Zhenlin Yang, Fei Shao, Hong Cheng, Yaru Wen, Sijin Sun, Wei Guo, Zitong Li, Fan Zhang, Liyan Xue, Nan Bi, Jie Wang, Yingli Sun, Yin Li, Fengwei Tan, Qi Xue, Shugeng Gao, Susheng Shi, Yibo Gao, Jie He
Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes. Nature communications 12 (1) (2021)
Zhenlin Yang, Yue Peng, Wei Guo, Jiachen Xu, Lin Li, He Tian, Renda Li, Lei Liu, Fengwei Tan, Shugeng Gao, Jie He
PD-L1 and CD47 co-expression predicts survival and enlightens future dual-targeting immunotherapy in non-small cell lung cancer. Thoracic cancer 12 (11) (2021)
Zhenlin Yang, Jiachen Xu, Lin Li, Renda Li, Yalong Wang, Yanhua Tian, Wei Guo, Zhijie Wang, Fengwei Tan, Jianming Ying, Yucheng Jiao, Shugeng Gao, Jie Wang, Yibo Gao, Jie He
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma. Nature communications 11 (1) (2020)
Zhenlin Yang, Jiachen Xu, Renda Li, Yibo Gao, Jie He
PD-L1 and CD47 co-expression in pulmonary sarcomatoid carcinoma: a predictor of poor prognosis and potential targets of future combined immunotherapy. Journal of cancer research and clinical oncology 145 (12) (2019)